Giuseppe Di Giovanni Selected Research

Vesicular Neurotransmitter Transport Proteins

8/2013

Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Di Giovanni Research Topics

Disease

26	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2006
14	Seizures (Absence Seizure) 01/2022 - 12/2009
14	Epilepsy (Aura) 01/2021 - 08/2013
6	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022 - 12/2009
5	Atherosclerotic Plaque (Atheroma) 12/2022 - 01/2018
5	Dyskinesias (Dyskinesia) 01/2022 - 11/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2014
5	Schizophrenia (Dementia Praecox) 12/2020 - 01/2008
4	Acute Coronary Syndrome 12/2022 - 01/2018
4	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2008
3	Myocardial Infarction 12/2022 - 01/2022
3	Tobacco Use Disorder (Nicotine Dependence) 04/2021 - 01/2007
3	Temporal Lobe Epilepsy 01/2021 - 08/2013
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 01/2019
3	Central Nervous System Diseases (CNS Diseases) 01/2021 - 11/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 06/2007
3	Nervous System Diseases (Neurological Disorders) 01/2016 - 01/2006
3	Motor Disorders 11/2011 - 01/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2018
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2020 - 05/2020
2	Pain (Aches) 09/2019 - 01/2019
2	Cognitive Dysfunction 07/2014 - 10/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	AIDS-Related Complex (ARC) 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Disease Progression 02/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Neuroblastoma 01/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Hypertension (High Blood Pressure) 05/2020
1	Cardiac Arrhythmias (Arrythmia) 05/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Obesity 01/2020
1	Inflammation (Inflammations) 01/2018
1	Atherosclerosis 01/2018
1	Neurobehavioral Manifestations 01/2017
1	Tauopathies 01/2016

Drug/Important Bio-Agent (IBA)

10	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2008
9	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2008
7	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 11/2011
4	LipidsIBA 12/2022 - 02/2021
4	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 12/2009
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2008
4	Oxidopamine (6 Hydroxydopamine)IBA 04/2020 - 02/2009
3	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2022 - 01/2019
3	CannabinoidsIBA 01/2022 - 11/2017
3	EndocannabinoidsIBA 01/2022 - 11/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2018
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 10/2013
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 01/2019
3	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2011 - 02/2009
2	evolocumabIBA 01/2022 - 02/2021
2	Nicotine FDA Link 04/2021 - 03/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2021
2	ConvulsantsIBA 01/2021 - 01/2019
2	lorcaserinIBA 01/2020 - 01/2020
2	tau Proteins (tau Protein)IBA 01/2017 - 01/2016
2	LigandsIBA 01/2016 - 01/2016
1	Colchicine FDA LinkGeneric 12/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2022
1	Cannabinoid Receptor AgonistsIBA 01/2022
1	SubtilisinIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	Proprotein Convertase 9IBA 02/2021
1	Biological ProductsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	GABA Plasma Membrane Transport ProteinsIBA 01/2020
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 09/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	ElementsIBA 01/2018
1	Cyclic NucleotidesIBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2018
1	CER-001IBA 01/2018
1	CholesterolIBA 01/2018
1	ICI D2788IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	MelatoninIBA 01/2016
1	Serotonin 5-HT2 Receptor AntagonistsIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 03/2015
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 02/2015
1	Connexin 43 (Connexin43)IBA 01/2015

Therapy/Procedure

6	Therapeutics 12/2022 - 06/2007
1	Deep Brain Stimulation 01/2019
1	Intravenous Infusions 01/2018